Characterization of LiF TLD‐100 in carbon ion beams for remote audits
TLD-100 can be used for passive dosimetry in a therapeutic carbon ion beam. Importantly, the linearity and beam quality correction factors are both different from photon therapy, and dependent on LET<sub>D</sub> of the carbon ion beam. This opens the possibility of TLD use for carbon ion output audits, phantom audits, and in vivo dose measurements, but may be subject to more complicated management and slightly larger uncertainties than are achieved in photon beams.
Authors
- Shannon Hartzell (ORCID: https://orcid.org/0000-0003-1289-7057)
- P Alvarez (ORCID: https://orcid.org/0000-0002-3788-3391)
- Eugene J. Koay (ORCID: https://orcid.org/0000-0001-7675-3461)
- Stephen F. Kry (ORCID: https://orcid.org/0000-0001-6899-197X)
- Paige A. Taylor (ORCID: https://orcid.org/0000-0001-9720-8059)
- Rebecca M. Howell (ORCID: https://orcid.org/0000-0002-0803-071X)
- C Peeler (ORCID: https://orcid.org/0000-0003-3418-076X)
- Giuseppe Magro (ORCID: https://orcid.org/0000-0001-7140-8642)
- Alfredo Mirandola (ORCID: https://orcid.org/0000-0003-2427-2329)
- Christine B. Peterson (ORCID: https://orcid.org/0000-0003-3316-0468)
- Mario Ciocca (ORCID: https://orcid.org/0000-0002-9311-8838)
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- Jacksonville College (US)
- WinnMed (US)
- National Center for Oncological Hadrontherapy (IT)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Medical Physics
- Published
- 2024-12-24
- DOI
- https://doi.org/10.1002/mp.17605
- Citations
- 3
- Primary Topic
- Radiation Effects in Electronics
- Type
- article
- Field-Weighted Citation Impact
- 0.63